The Care Gap

$672M

Hospital EHR by 2030

$150M

Pharma RWE by 2030

$15M+

Solo-Practice Floor by 2030

Earlier Intervention

Improved Patient Outcomes

Treatment Decisions Based on Memory

Cancer and other chronic disease patients see their doctor every 3-4 months. The physician asks "How have you been?" and makes critical treatment decisions based on what the patient remembers from 90+ days. No continuous vitals. No side effect trends. No medication adherence data.

Mental Health Left Behind

280 million people live with depression. Physical symptoms in one system, mental health in another. Oncologists don't see depression scores. Psychiatrists don't see cancer vitals. The patient falls through the gap.

Language Barriers Kill

Limited English proficiency patients face 2-3x higher mortality rates. Misunderstood treatment instructions. Medication errors. 9 out of 10 health apps don't support their language.

The Solution

Free patient app captures daily patient-reported data through a growing library of 19 live tracking modules, aligned to our first 8 chronic disease communities and available in 116 languages. With patient or authorized caregiver consent, ProviderConnect™ turns episodic care into continuous, reviewable monitoring.

ProviderConnect™

What Patients Track

Patients and caregivers use a growing suite of 19 Tracking Calendar modules, with more added as user groups identify additional needs. The system captures the key symptoms and day-to-day realities reported across chronic disease communities and lived experience, including blood pressure, mental health (PHQ-9), side effects, nutrition, pain levels, hydration, GI function, medication adherence, weight, sleep quality, and more.

Rolling 90-day analysis surfaces patterns that rarely appear inside quarterly appointments.

What Physicians See

ProviderConnect™ gives clinicians a fast review layer across 90 days of home tracking: symptom trends, medication adherence, side-effect signals, mental health scores, and escalation flags in one place. That supports earlier intervention, stronger documentation, and fewer decisions made from isolated appointment snapshots.

Integrated Mental Health

Mental health and physical health are tracked together because treatment reality is never split cleanly. Depression, anxiety, isolation, sleep disruption, pain, and adherence breakdowns often move before deterioration is obvious in clinic. ProviderConnect™ helps care teams see those linked signals earlier and respond sooner.

Reactive → Proactive

Before: "Your cancer spread because we didn't catch warning signs 2 months ago"
After: "Your vitals show early kidney stress from chemo-let's adjust dosage before damage occurs"

All data sharing subject to patient or authorized caregiver consent.

Revenue Model

Three Revenue Streams

Enterprise Subscriptions ($15/patient/month): Hospitals reduce readmissions, improve HCAHPS scores, capture CMS quality bonuses. CMS reimburses $19-61/patient/month for remote monitoring-our pricing is 75%+ below their cost.

Pharmaceutical RWE Licensing: Post-market surveillance tracking 10,000+ patients in real-world conditions. Track efficacy across demographics, catch side effects missed in trials, optimize dosing. Better data prevents billion-dollar recalls and accelerates FDA approvals.

Solo Practitioner Subscriptions ($5/patient/month): Patient-driven bottom-up demand. "My patient uses CareHub, I need access." In the current model this is deliberately treated as a conservative floor rather than the main global growth engine: roughly 250K patient seats across 6,250 practices by 2030, generating about $15M ARR before larger groups convert into higher-value provider-network or enterprise deals.

Rationale check: The $15M solo-practice line is not meant to represent the total global practitioner opportunity. It is a deliberately restrained bottom-up assumption so the global case is carried by enterprise health-system adoption and pharma RWE, not by optimistic small-practice math.

5-Year Projection

Year	Disease Modules	EHR Patients	Total ARR
2026	Cancer, Alzheimer's	40-80K	$4-8M
2027	+ Autism, Aged Care	300K	$42M
2028	+ Parkinson's, Type II Diabetes	1.2M	$158M
2029	+ Obesity, Long COVID	3.5M	$446M
2030	All 8 at scale	8.2M	$1.046B

IPO Target: ~$10.5B (2030)

$1.046B+ ARR at 10x SaaS revenue multiple
8.2M enterprise patients across 8 chronic conditions
116 languages with automated expansion
Patient app stays free forever-enterprise revenue funds everything

What Makes Us Different

One Token Across 8 Conditions

Most health apps focus on one disease. We use one token across all conditions: Cancer, Alzheimer's, Autism, Parkinson's, Long COVID, Obesity, Type II Diabetes, Aged Care. Network effects compound not just across patients, but across caregivers, family supporters, and clinicians moving between overlapping care journeys on the same platform.

That multiplier is especially visible in dementia-heavy cohorts. Alzheimer's Association 2025 data shows 7.2 million Americans living with Alzheimer's and nearly 12 million unpaid caregivers, implying an approximately 1.6-1.7 caregiver-per-patient baseline, with larger support networks common in higher-acuity cases. That makes CareHub more than a patient app: it becomes care infrastructure for the wider support ecosystem.

Source: Alzheimer's Association 2025 Facts and Figures; author research synthesis across cancer and dementia caregiver-network patterns.

116 Languages Now

Most apps launch in 2-3 languages and call it "global." We support 116 locales with automated weekly expansion via i18next. Cross-disease progression data in Mandarin, Arabic, Navajo worth billions to pharma. Competitors are years behind.

Cultural Ambassadors

9 strategic community leaders opening doors in markets competitors can't access: tribal lands, favelas, rural Africa, immigrant communities. Trusted entry where traditional marketing fails. Replicating this network takes years.

Why Now

Long COVID created 400 million people who need long-term health tracking. Telehealth normalized during the pandemic. AI finally enables personalized insights at scale. The infrastructure exists. The market is ready. Competitors are still building single-disease apps. By the time they realize one platform across 8 conditions creates network effects, we'll have 2+ years of patient data they can't replicate.

Winner-Take-Most Dynamics

Cross-disease insights: Tracking cancer→Alzheimer's risk, obesity→mental health-pharmaceutical licensing gold
Multilingual data monopoly: Only platform capturing progression data in 116 languages across 8 conditions
Geographic barriers: First-mover advantage in underserved markets competitors can't enter
Patient lock-in: 2+ years of health data creates insurmountable switching costs

Awards Program

Tiered Awards Structure

Year 1 (Alzheimer's, Cancer, and Long COVID Communities) - $8,750 Total in the moderate 2026 case:

1 annual award per condition: one annual award each for Alzheimer's, Cancer, and Long COVID
4 quarterly cross-condition creative awards: Child, Teen, Young Adult, and Adult categories
Enterprise-linked envelope: the current conservative to aggressive 2026 range remains $6.3K-$13.3K, with $8.75K as the moderate planning case

Year 2 Expansion: Awards extend to Autism, Parkinson's, Aged Care, Obesity, and Type II Diabetes in step with the same enterprise-linked award-intensity ratio used on the awards page.

Provider Recognition: Provider recognition remains part of the broader program architecture as award capacity expands.

How Awards Are Funded

Year 1: The current enterprise-linked launch envelope is $6.3K-$13.3K, with $8.75K as the moderate 2026 planning case for the initial Alzheimer's, Cancer, and Long COVID rollout.

Years 2+: Funded from enterprise revenue:

Enterprise subscriptions ($15/patient/month)
Solo practitioner subscriptions ($5/patient/month)
Pharma RWE data licensing ($500K-$5M/partner)
Transaction fees (1%)

Token Appreciation Potential: Awards are paid in tokens at current market value. Early recipients who hold tokens may benefit from platform growth, but this is speculative upside-not guaranteed. Under the current launch model, quarterly creative awards are modest fixed-dollar awards and the three annual condition awards share the remaining enterprise-linked envelope for immediate liquidity.

Methodology note: The awards envelope uses the same enterprise-linked planning logic as the awards page. The current moderate launch ratio is $8.75K on $15M ARR, or 0.0583%, applied across the synced enterprise scenarios.

Source basis: The 2026, 2027, 2028, and 2030 planning anchors referenced here are taken from the current Enterprise forecast and kept in sync with the awards program assumptions.

Revenue Sharing Model: Patients Deserve To Benefit

Traditional healthcare extracts patient data for profit (pharma, hospitals, insurers make billions) but patients get nothing. We flip this model:

Patients contribute data: Daily vitals, side effects, treatment outcomes create value
Patients earn tokens: Log vitals = earn tokens. Participate in community = earn tokens. Complete surveys = earn tokens. These are digital assets with real monetary value, not gamification points.
Patients receive awards: Quarterly creative awards plus annual condition-level recognition under the current launch model.
Community-directed research: Tokenized ecosystem funds patient-driven research. Community votes on research priorities.

Revenue sharing: Hospitals pay $15/patient/month for provider access, pharma pays $500K-$5M for RWE data licensing-we share that revenue back with patients through token rewards and awards. Your data generates value; you deserve to benefit.

Award Categories

Warrior Awards: Recognizing patients battling chronic disease with courage and resilience
Caregiver Awards: Honoring the dedication of family members and caregivers
Creative Awards: Celebrating community contributions (Vibe designs, music, stories)
Provider Awards: Recognizing healthcare professionals delivering exceptional care

All award stories preserved on blockchain-permanent, globally accessible testament to human resilience.

116 Languages

Live today across the active CareHub locale set.

6 Continents

Coverage spans the major global care and caregiver markets.

7.8B Speakers

Designed to meet patients and caregivers in-language at scale.

Weekly Expansion

New i18next locales can be evaluated and added without phased rollout delays.

116 Locales. Automated Expansion.

Every language available in the "i18next" vendor system is now supported in CareHub. We receive automated weekly email notifications when new languages become available and add them to the database immediately.

No phased rollout.
No waiting.
If the translation framework supports it, so do we.

What We Cover

Major languages: English, Spanish, Mandarin, Arabic, French, German, Portuguese, Japanese, Russian, Hindi, Bengali, Korean, and 100+ more
RTL support: Arabic, Hebrew, Farsi, Urdu with full right-to-left rendering
Indigenous languages: Navajo, Cree, Māori, Quechua, and others as i18next adds support
African languages: Swahili, Zulu, Amharic, Hausa, Yoruba, and 15+ more

Linguistic Equity Saves Lives

Limited English Proficiency patients face 2-3x higher mortality rates. Misunderstood treatment instructions. Medication errors. CareHub serves every patient in their language, not just the profitable demographics.

Speak a Language We Don't Offer?

If your language isn't in our 116 locales, we want to know. Contact research.carehub@gmail.com and we'll research adding it. Our commitment: if it's technically possible, we'll make it happen.

Multilingual Data Monopoly

Cross-disease progression data in 116 languages-pharmaceutical licensing gold for global clinical trials
Professional medical validation: Native-speaking healthcare professionals verify terminology accuracy
Years ahead of competitors: Most apps support 2-5 languages. We support 116. First-mover advantage is permanent.

Leadership

David Lennard, Founder-6-year cancer warrior with multiple myeloma, purpose-driven to find solutions to help close what he calls "The Care Gap".

Career marketing strategist with:

senior executive startup experience
direct mail, catalog, e-commerce and b2b marketing
leadership roles at two ASX-listed blue-chip corporations
P & L and General Ledger Accountability
cost of goods, ROI and inventory accountability and planning
Brand and Product development
offshore sourcing across multiple commodity groups
offshore development of CMT (cut, make and trim) textiles, clothing and footwear, taking advantage of global preferential tariff and quota systems

Founder Authenticity: Lived Experience + Executive Expertise

David builds CareHub to solve his own survival challenge as a 6-year cancer warrior, creating solutions that work for millions facing similar battles:

Lived experience: 6 years navigating multiple myeloma-understanding pain points developers miss (2am side effects, caregiver guilt, financial toxicity)
Community trust: "One of us" builds loyalty focus groups can't replicate
Product-market fit: Features prioritized by real need-voice tech for speech-impaired, consent tracking, multilingual support
Marketing advantage: "Cancer warrior building lifeline" resonates deeper than "Silicon Valley disrupts healthcare"
Legacy commitment: Platform must work for David's survival-quality standards competitors can't match

Built under extreme personal constraint: CareHub wasn't built on a Silicon Valley salary, venture-backed engineering team, or corporate safety net. It was built by one person over more than 4 years, through more than 35 moves between a tent in the desert, a shed, homeless shelters, trailers, and whatever shelter was available when funds allowed. All on a borrowed MacBook Air, with no coding background.

This is not framed for sympathy. It is evidence of resilience, mission discipline, and unusual execution endurance: the platform kept moving forward through illness, instability, and recovery because the purpose was always bigger than the founder himself.

Senior executive experience (ASX blue-chips + startups) provides operational sophistication. Cancer journey provides mission clarity. This combination attracts patients, ambassadors, enterprise partners, and purpose-driven investors.

Corporate Structure: Delaware Public Benefit Corporation

CareHub incorporates as a Delaware PBC-legally enshrining patient-first mission while enabling venture-scale returns. This is NOT a DAO (vulnerable to whale capture, regulatory risk, mission drift). It is designed as a hybrid structure that preserves mission control, limits corruptibility, and prevents a conventional sell-out dynamic even if up to 49% eventually proceeds to IPO/public-market ownership. Four founder tiers align incentives:

Tier	Investment	Allocation	IPO Value ($25)
Principal Founder	$350,000	6% (30M tokens)	$750M
Co-Founders (7)	$50,000 each	2% each (10M tokens)	$250M each
Founding Council (100)	$1,000 each	0.5% total (25K each)	$625K each
Honorary Founders (3)	$0 (contribution-based)	0.09% total (150K each)	$3.75M each
Total	$800,000	20.59%	$2.57B

Why this structure works:

Principal Founder ($350K for 6%): Reflects 6+ years of uncompensated full-time work, 17,000+ hours of development, solo invention from scratch, and the fact that CareHub was built by one founder under severe personal hardship rather than with a paid startup team. Even at this revised number, the ask remains a discounted recovery-of-time figure, not a conventional Silicon Valley founder package.
Co-Founders ($50K for 2%): Priced as a later-entry operator tier for exceptional execution partners joining an already invented and already built platform. At $25K per 1%, this remains a fair mission-aligned entry point without implying parity with the principal founder's invention risk, solo build effort, or 6+ years of uncompensated platform creation.
Founding Council ($1K): Accessible entry for mission-aligned patients/caregivers/HCPs with advisory voting rights (curated, not whale-captured)
Honorary Founders ($0): Reserved for exceptional patient and caregiver contributors whose lived experience materially shapes the platform

The nuanced difference matters. Recent AI stories can show one person replacing a marketing team or compressing a single operating function. CareHub goes materially further: one founder invented the system, specified it from scratch, and built an entire patient, caregiver, provider, enterprise, governance, token, multilingual, and impact ecosystem-solo.

Recent AI Signal

For people frightened by the phrase “AI in cancer care,” this is the more useful framing: AI is increasingly acting as an accelerant for research paths, hypothesis generation, and time-sensitive coordination, not just a chatbot gimmick.

Fortune reported on March 15, 2026 that Australian entrepreneur Paul Conyngham used ChatGPT and AlphaFold to help navigate a path toward a bespoke mRNA cancer vaccine for his dog Rosie, working with Australian scientists and the University of New South Wales. Most of Rosie’s tumours reportedly shrank, and her quality of life improved, with the researchers explicitly framing the case as frontier personalized-medicine work that may ultimately help humans.

The reason this matters here is broader than the story itself: if AI can already help compress oncology-adjacent discovery and coordination in emotionally urgent, resource-constrained conditions, then the market should also re-rate what a determined founder can build, validate, and operationalize with the right mission and enough endurance.

Why CareHub Chose LLMs

I chose large language models to help build CareHub from the ground up because they made it possible to leave fewer stones unturned. Used correctly, they can accelerate synthesis, scenario testing, systems thinking, and draft exploration at a speed that would otherwise take researchers, analysts, and actuaries years or decades to replicate across so many interlocking domains.

What CareHub represents was not the result of one prompt and a publish button. The platform was built through roughly 18 months of focused construction, followed by relentless auditing, re-auditing, and manual review by eye and by hand. That is the real story: LLMs accelerated exploration, but human judgment did the filtering, correction, prioritization, and final design work.

That principle applies across the enterprise. Whether the opportunity is a vendor-subsidized solar program for remote clinics, VR equipment for therapeutic support, or AI-driven functionality inside the product, the architecture is human-led, reviewed against mission fit, and shaped through consultation with hundreds of people across lived experience, caregivers, clinicians, researchers, and community stakeholders.

This is part of enterprise value, not a side note. CareHub's AI integration policy is grounded in human oversight, privacy-first controls, and mission discipline: LLMs do not determine our strategy, and they do not get a free claim on our users' data. We use AI to extend human capability, not replace accountable decision-making.

CareHub AI posture: Ask Rupert / AI experience · Security & Privacy · Privacy Policy

Source: Fortune, March 15, 2026. Read article

That ecosystem includes a tracking architecture designed to save lives and improve outcomes physically and mentally, wrapped inside a mission-locked Delaware PBC structure built to resist corruption-an increasingly important trust advantage in a world of rising privacy fears, data misuse concerns, and Palantir-style anxieties about who ultimately controls health infrastructure.

Investors are not being asked to fund a blank page. They are being offered a platform already built through extraordinary founder sacrifice, at an entry number that remains far below what a conventional market-rate team, agency stack, acquisition-style talent outcome, or replacement-cost analysis would normally imply. The founder has built this through more than 35 moves over the last several years-with shelter only when funds allowed, at times barely surviving on $68 per month in food stamps, and donations, without salary, using a borrowed 8GB MacBook Air hot-wired to external SSDs and determination.

There has effectively been no day off since being hospitalised. That continuity matters because it shows the underlying motive is service: to build something useful enough to reduce suffering for other patients, caregivers, and clinicians navigating the same chaos.

Founder recruitment opens in July 2026, and the $800,000 raise funds the initial 12-month operating plan through June 2027 while ICO preparation continues in parallel. Full founder details →